• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类乙酰胆碱酯酶潜在抑制剂的发现:分子对接与分子动力学研究

Discovery of potential inhibitor against human acetylcholinesterase: a molecular docking and molecular dynamics investigation.

作者信息

Singh Surya Pratap, Gupta Dwijendra

机构信息

Center of Bioinformatics, University of Allahabad, Allahabad 211002, India; Department of Bioscience and Biotechnology, Banasthali University, Banasthali 304022, India.

Center of Bioinformatics, University of Allahabad, Allahabad 211002, India; Department of Biochemistry, University of Allahabad, Allahabad 211002, India.

出版信息

Comput Biol Chem. 2017 Jun;68:224-230. doi: 10.1016/j.compbiolchem.2017.04.002. Epub 2017 Apr 12.

DOI:10.1016/j.compbiolchem.2017.04.002
PMID:28432980
Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease of central nervous system among elderly people. Human acetylcholinesterase (hAChE), an important enzyme in neuronal signaling, is responsible for the degradation of acetylcholine which in turn prevents the post synaptic signal transmissions. hAChE has been an attractive target of drug discovery for the search of therapeutics against AD. In the recent past hAChE has become hot target for the investigation of new potential therapeutics. We performed virtual screening of entire database against hAChE. Further, the extra precision molecular docking was carried out to refine the docking results and the best complex was passed for molecular dynamics simulations in order of understanding the hAChE dynamics and its behavior in complex with the ligand which corroborate the outcomes of virtual screening. This also provides binding free energy data that establishes the ligands efficiency for inhibiting hAChE. The computational findings discussed in this paper provide initial information of inhibitory effects of ligand, (drugbank entry DB00983), over hAChE.

摘要

阿尔茨海默病(AD)是老年人中枢神经系统的一种进行性神经退行性疾病。人乙酰胆碱酯酶(hAChE)是神经元信号传导中的一种重要酶,负责乙酰胆碱的降解,进而阻止突触后信号传递。hAChE一直是药物研发中寻找AD治疗药物的一个有吸引力的靶点。最近,hAChE已成为研究新的潜在治疗方法的热门靶点。我们对整个数据库进行了针对hAChE的虚拟筛选。此外,进行了额外精度的分子对接以优化对接结果,并将最佳复合物用于分子动力学模拟,以了解hAChE的动力学及其与配体结合时的行为,这证实了虚拟筛选的结果。这还提供了结合自由能数据,确定了配体抑制hAChE的效率。本文讨论的计算结果提供了配体(药物银行条目DB00983)对hAChE抑制作用的初步信息。

相似文献

1
Discovery of potential inhibitor against human acetylcholinesterase: a molecular docking and molecular dynamics investigation.人类乙酰胆碱酯酶潜在抑制剂的发现:分子对接与分子动力学研究
Comput Biol Chem. 2017 Jun;68:224-230. doi: 10.1016/j.compbiolchem.2017.04.002. Epub 2017 Apr 12.
2
Similarity search combined with docking and molecular dynamics for novel hAChE inhibitor scaffolds.结合对接和分子动力学的相似性搜索用于新型人乙酰胆碱酯酶抑制剂支架
J Mol Model. 2018 Jan 13;24(1):41. doi: 10.1007/s00894-017-3548-9.
3
In-silico and in-vitro evaluation of human acetylcholinesterase inhibition by organophosphates.有机磷对人乙酰胆碱酯酶抑制的计算机模拟和体外评估。
Environ Toxicol Pharmacol. 2018 Jan;57:131-140. doi: 10.1016/j.etap.2017.12.014. Epub 2017 Dec 17.
4
The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays.通过药效团建模、虚拟筛选、对接模拟和生物测定发现新型乙酰胆碱酯酶抑制剂。
Mol Biosyst. 2016 Nov 15;12(12):3734-3742. doi: 10.1039/c6mb00661b.
5
Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study.协同氢键和非芳香环的流动性作为人类乙酰胆碱酯酶对类似抗阿尔茨海默病加兰他敏类化合物的选择性决定因素:一项计算研究。
J Biomol Struct Dyn. 2019 Apr;37(7):1843-1856. doi: 10.1080/07391102.2018.1470036. Epub 2018 May 17.
6
In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.阿尔茨海默病乙酰胆碱酯酶和聚(ADP-核糖)聚合酶-1双靶点抑制剂的计算机模拟鉴定
J Mol Model. 2018 Jun 5;24(7):151. doi: 10.1007/s00894-018-3696-6.
7
A new role for the nonpathogenic nonsynonymous single-nucleotide polymorphisms of acetylcholinesterase in the treatment of Alzheimer's disease: a computational study.乙酰胆碱酯酶非致病性非同义单核苷酸多态性在阿尔茨海默病治疗中的新作用:一项计算研究
J Comput Biol. 2014 Aug;21(8):632-47. doi: 10.1089/cmb.2014.0005. Epub 2014 Mar 10.
8
Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer's disease.虚拟筛选和分子动力学模拟方法鉴定阿尔茨海默病治疗的多靶标导向配体。
J Biomol Struct Dyn. 2024 Jan-Feb;42(1):509-527. doi: 10.1080/07391102.2023.2201838. Epub 2023 Apr 28.
9
Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.发现新型乙酰胆碱酯酶抑制剂作为治疗阿尔茨海默病的潜在候选药物。
Int J Mol Sci. 2019 Feb 25;20(4):1000. doi: 10.3390/ijms20041000.
10
Positive cooperative regulation of double binding sites for human acetylcholinesterase.人乙酰胆碱酯酶双结合位点的正向协同调节
Chem Biol Drug Des. 2017 May;89(5):694-704. doi: 10.1111/cbdd.12891. Epub 2016 Nov 19.

引用本文的文献

1
Golden Oyster Mushroom Extract Ameliorates Oxidative Stress-Induced Cell Death in Neurons and Scopolamine-Induced Cholinergic System Impairment in Mice.金顶侧耳提取物可改善氧化应激诱导的神经元细胞死亡以及东莨菪碱诱导的小鼠胆碱能系统损伤。
Mol Neurobiol. 2025 Jul 19. doi: 10.1007/s12035-025-05223-7.
2
Drug delivery strategies with lipid-based nanoparticles for Alzheimer's disease treatment.用于阿尔茨海默病治疗的基于脂质纳米颗粒的药物递送策略。
J Nanobiotechnology. 2025 Feb 10;23(1):99. doi: 10.1186/s12951-025-03109-3.
3
Bauhinia coccinea extract prevents memory loss induced by scopolamine through activation of antiapoptotic and antioxidant pathways in mice.
红花羊蹄甲提取物通过激活小鼠的抗凋亡和抗氧化途径来预防东莨菪碱诱导的记忆丧失。
Sci Rep. 2025 Feb 3;15(1):4037. doi: 10.1038/s41598-025-88152-8.
4
(m) RVD-hemopressin (α) Ameliorated Oxidative Stress, Apoptosis and Damage to the BDNF/TrkB/Akt Pathway Induced by Scopolamine in HT22 Cells.(m)RVD-hemopressin(α)可改善东莨菪碱诱导的 HT22 细胞氧化应激、细胞凋亡及 BDNF/TrkB/Akt 通路损伤。
Neurotox Res. 2023 Dec;41(6):627-637. doi: 10.1007/s12640-023-00677-w. Epub 2023 Nov 16.
5
Development of substituted benzylidene derivatives as novel dual cholinesterase inhibitors for Alzheimer's treatment.开发取代亚苄基衍生物作为治疗阿尔茨海默病的新型双胆碱酯酶抑制剂。
RSC Adv. 2023 Sep 4;13(38):26344-26356. doi: 10.1039/d3ra03224h.
6
Effects of linalyl acetate on oxidative stress, inflammation and endothelial dysfunction: can linalyl acetate prevent mild cognitive impairment?乙酸芳樟酯对氧化应激、炎症和内皮功能障碍的影响:乙酸芳樟酯能否预防轻度认知障碍?
Front Pharmacol. 2023 Jul 28;14:1233977. doi: 10.3389/fphar.2023.1233977. eCollection 2023.
7
Indene-Derived Hydrazides Targeting Acetylcholinesterase Enzyme in Alzheimer's: Design, Synthesis, and Biological Evaluation.针对阿尔茨海默病中乙酰胆碱酯酶的茚衍生酰肼类化合物:设计、合成及生物学评价
Pharmaceutics. 2022 Dec 28;15(1):94. doi: 10.3390/pharmaceutics15010094.
8
Role of Cholinergic Signaling in Alzheimer's Disease.胆碱能信号在阿尔茨海默病中的作用。
Molecules. 2022 Mar 10;27(6):1816. doi: 10.3390/molecules27061816.
9
FDA-Approved Oximes and Their Significance in Medicinal Chemistry.美国食品药品监督管理局批准的肟类化合物及其在药物化学中的意义。
Pharmaceuticals (Basel). 2022 Jan 4;15(1):66. doi: 10.3390/ph15010066.
10
A Comprehensive Review of Cholinesterase Modeling and Simulation.胆碱酯酶建模与模拟的综合述评
Biomolecules. 2021 Apr 15;11(4):580. doi: 10.3390/biom11040580.